Bristol-Myers Squibb Co. | Shareholders Foundation

Bristol-Myers Squibb Co.

NYSE: BMY

Investor Relations

Related Securities

Symbol	Description
NYSE: BMY-	Bristol-Myers Squibb Co., $2.00 Convertible Preferred Stock
NYSE: KNR	Structured Products CorTS, Bristol-Myers Squibb Deb, 6.80% Certificates
NYSE: XFR	Lehman ABS Corp Bkd Trust Certs 2002-18, 6.25% Bristo-Myers Squibb

There is 1 Investigation and 4 Cases being monitored for this company.

Case Name	Date Filed	Updated	Status	Securities
Bristol-Myers Squibb Co (NYSE: BMY) Investor Securities Class Action Lawsuit 02/09/2018	02/09/2018	05/20/ 2018	Case Dismissed	NYSE: BMY
Bristol-Myers Squibb Co (NYSE:BMY) InvestorLawsuit Against Certain Directors Filed	09/06/2016	09/12/ 2016	Lawsuit Filed	NYSE: BMY
Bristol-Myers Squibb Company (NYSE: BMY) Investor Securities Class Action Lawsuit 06/20/2007	06/20/2007	09/28/ 2014	Lawsuit Filed Settlement Approved	NYSE: BMY
Bristol-Myers Squibb Co. Case 03/22/2002	03/22/2002	07/02/ 2010	Lawsuit Filed Judgment Issued Settlement Proposed Settlement Approved	NYSE: BMY

Title	Securities
Bristol-Myers Squibb Co (NYSE:BMY) Investor Investigation Concerning Possible Breaches Of Fiduciary Duties Announced	NYSE: BMY